A study by Przybyl et al. found that EWS-FLI1/ERG in either tumor or peripheral blood samples did not have prognostic value; however, they did find that cadherin 2 (CDH2) downregulation in peripheral blood samples of ES patients correlated to worse overall survival. This evidence concerns the gene FLI1 and neoplasm.